CFO Corner: Anne-Laure Autret-Cornet, OSE Immunotherapeutics
Global Finance
MARCH 4, 2025
The uncertainty and rapid changes in the global market required quick adaptation and strategic financial planning to ensure the stability and continuity of our operations. And we have ongoing important collaborations with other companies such as Boehringer Ingelheim and Veloxis Pharmaceuticals.
Let's personalize your content